Benzinga's Top Downgrades

Analysts at Deutsche Bank downgraded LHC Group LHCG from “buy” to “hold.” The target price for LHC Group is set to $23. LHC Group's shares closed at $23.36 yesterday. Analysts at JP Morgan downgraded Synageva BioPharma GEVA from “overweight” to “neutral.” The target price for Synageva BioPharma has been lowered from $57 to $50. Synageva BioPharma's shares closed at $45.79 yesterday. Analysts at Canaccord Genuity downgraded Rent-A-Center RCII from “buy” to “hold.” The target price for Rent-A-Center has been lowered from $42.00 to $37.00. Rent-A-Center's shares closed at $35.80 yesterday. McNicoll Lewis Vlak downgraded Transcept Pharmaceuticals TSPT from “buy” to “hold.” The target price for Transcept Pharmaceuticals is set to $3. Transcept Pharmaceuticals' shares closed at $3.09 yesterday.